Actively Recruiting
Improving Bladder Function in SCI by Neuromodulation
Led by University of California, Los Angeles · Updated on 2026-02-13
24
Participants Needed
1
Research Sites
595 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.
CONDITIONS
Official Title
Improving Bladder Function in SCI by Neuromodulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male aged 18 to 45 years
- At least 1 year post spinal cord injury
- Non-progressive spinal cord injury at levels C2 to T8 (not involving conus)
- Motor complete injury classified as ASIA A or B
- Neurogenic bladder requiring clean intermittent straight catheterization
- Able to attend testing sessions twice weekly for 6 months
- Intact lower extremity anatomy and able to use lower extremities for assisted standing and stepping
You will not qualify if you...
- History of autonomic dysreflexia
- Ventilator dependency
- Musculoskeletal dysfunction, unhealed fracture, pressure ulcer, or active infection
- Clinically significant depression or ongoing drug abuse
- Prior botox injection or bladder surgery such as suprapubic access or Brindley procedure
- Prostatic hypertrophy or bladder outlet disorder
- Cardiopulmonary disease preventing lower extremity training or rehabilitation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
D
Daniel Lu, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here